Novel Quinazoline Derivative Induces Differentiation of Keratinocytes and Enhances Skin Barrier Functions Against Th2 Cytokine-Mediated Signaling
August 2023
in “
Molecules
”
Studysummary This study found that a quinazoline derivative, SH-340, increased skin barrier-associated factors and inhibited TSLP expression and STAT6 phosphorylation in human primary keratinocytes, suggesting potential benefits for alleviating inflammation and improving skin barrier function in atopic dermatitis.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer